tration of diazoxide. Western blot demonstrated that the mitoK ATP channels regulated the expression of connexin 43 (P2; active form) and connexin 45 in the epileptic hippocampus. These findings demonstrate that activation of astrocytic mitoK ATP channels improves the GJ function in astrocytes, indicating that the effect of the astrocytic mitoK ATP channels on neurotoxin-induced neurodysfunction might be, in part, through the regulation of the GJ-coupled spatial buffering in the hippocampus.
Introduction
The ATP-sensitive potassium (K ATP ) channels, which couple cell metabolism to electrical activity, participate in some important biological processes including neuronal transmission [1, 2] . K ATP channels are located in various parts of the cell, including the surface of the plasmalemmal membrane (sK ATP ) and the inner mitochondrial membrane (mitoK ATP ) [3] [4] [5] [6] . Manipulation of the K ATP channel status in various cellular types and at various intracellular locations has shown a variety of functional roles [3, [7] [8] [9] [10] . It has been revealed that neuronal K ATP channels in the brain are involved in the control of neuronal excitability [11] [12] [13] and seizure propagation [1, [14] [15] [16] [17] [18] [19] . The roles that glial K ATP channels play are receiving renewed attention due to improved understanding of the molecular events underpinning the physiological functions of glial cells. Recent studies have shown that opening the astrocytic mitoK ATP channels with drugs or by physiological stimuli can exert effects on glutamate uptake and astrocytic activation [20] [21] [22] [23] . However, the role of astrocytic mitoK ATP channels in the brain, in particular their contribution to pathogenesis of neurological disorders such as epileptogenesis, is largely unknown.
The more established function of astrocytes in the brain is in regulating the extracellular milieu. If K + regulation fails, pathological events such as epileptiform activity may be initiated [24] [25] [26] . One of the key mechanisms proposed to underlie astrocytic K + regulation is the spatial redistribution of K + termed spatial buffering [27] . Generally, the extensive linkage of astrocytes via the gap junctions (GJs) has been assumed to be essential for spatial buffering [28] . Astrocytic GJ-regulated K + buffering is involved in the control of epileptiform activity [24, 29, 30] ; however, a large capacity for K + clearance was conserved in mice with coupling-deficient astrocytes, indicating that GJ-dependent processes only partially account for K + buffering [24] . Astrocytic GJ-regulated K + buffering is also believed to remove K + by spatial buffering, possibly through inwardly rectifying potassium channels that enable uptake and redistribution of extracellular K + [31] . Therefore, we asked whether there is cooperation between the GJs and the astrocytic inwardly rectifying potassium channels, in particular the astrocytic mitoK ATP channels, and whether manipulation of the astrocytic mitoK ATP channels has an effect on neurotoxin-induced neurodysfunction via regulating spatial buffering.
In the study described here, we examined the effects of mitoK ATP channels on gap junctional functions in cultured astrocytes as well as in the hippocampus in a chronic picrotoxin (PTX) kindling epileptic model to determine: (a) whether activation of astrocytic mitoK ATP channels regulates gap junctional dye coupling; (b) whether mitoK ATP channel openers regulate astrocytic mitoK ATP channels against neurotoxin-induced dysfunction of astrocytic GJ intercellular communication (GJIC), and (c) the effect of astrocytic mitoK ATP channel-modulated astrocytic GJ coupling on PTX-induced neurodysfunction in vivo.
Materials and Methods

Cell Cultures
Astrocytes and primary neuronal cultures of rat brain were prepared as described previously [32, 33] (for details of methods, see online supplement, www.karger.com/doi/10.1159/000323575). For the experiments of scrape-loading and fluorescence recovery after photobleaching (FRAP), the astrocytic suspension ( ϳ 1 ! 10 5 cells/ml) was cultured on glass coverslips (32 mm in diameter) coated with poly( L -lysine) in a CO 2 incubator.
Intracellular Lucifer Yellow Loading
GJIC was determined by the scrape-loading dye transfer technique [33] . Cultures were incubated for 10 min in Hepes buffer (in m M : 140 NaCl, 5.5 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 Hepes, pH 7.3), and post-washed with Ca 2+ -free Hepes solution. Loading was achieved by scraping the cultures with a razor blade in the Ca 2+ -free Hepes buffer containing 0.1% (w/v) lucifer yellow (LY; dilithium salt; Sigma). After incubation (37 ° C) for 8 min, dye transfer between coupled cells was assessed by taking five successive photomicrographs/trial with an inverted microscope equipped with appropriate filters. The number of LY-loaded cell layers reflects the function of GJIC.
Determination of GJIC and Live Imaging
Cultures were incubated (37 ° C) with 15 g/ml 6-carboxyfluorescein diacetate (Sigma) for 20 min and then with D-Hanks' solution, free of 6-carboxyfluorescein diacetate for another 20 min (37 ° C) to allow complete de-esterification. A confocal scanning microscope (Zeiss 510) was used for imaging the 6-carboxyfluorescein diacetate signal. Excitation was provided by the 488-nm line of a krypton/argon laser, and emission was collected at its maximum of 530 nm. After a baseline fluorescence image of the cultures was obtained, the regions of interest (ROIs) were selected to include 4 or 5 cells for bleaching and 5 cells for controlling/dish. ROIs were first scanned with an argon 488 laser at 5-10% power for 5 cycles to determine a measurement of initial fluorescence intensity in the ROI. This value was taken as 100%. Next, ROIs were subjected to photobleaching with an argon 488 laser at full power. The fluorescence intensity of the ROI was then measured at 1, 2, 5 and 8 min after bleaching at 5-10% laser power to measure fluorescence recovery relative to the initial settings in the ROI. All values of fluorescence intensity in the ROIs were obtained by subtracting the background fluorescence from an identical membrane area that did not have detectable fluorescence. The fluorescence recovery percentage at each time point was calculated as:
where I t is fluorescence intensity in the ROI at the given time point, I 0 is the intensity of fluorescence in ROI after photobleaching, and I c is the average value of 5 measurements of fluorescence intensity in the ROI before photobleaching.
Chemical Preparations and Administration
Diazoxide (Dia; 0.1 m M ), 5-hydroxydecanoate (5-HD; 1 m M ), 18a-glycyrrhetinic acid (AGA; 0.01 m M ) and kainic acid (KA; 0.05 m M ; all from Sigma) were dissolved in DMSO and then diluted to the required concentrations with the culture medium. For scrapeloading and FRAP cells, we applied the chemicals 1 h before start-ing the tests. For the Western blot, we treated the cultures with chemicals for 5 days before the protein extraction. For 6-day-old primary neuronal cultures, the neurons were treated with chemicals for 1 h, post-washed and incubated (37 ° C) with the normal culture medium for another 1 h, and the culture medium (without cells or chemicals) was collected and used to incubate (37 ° C) the astrocytic cultures for 1 h before starting the FRAP tests.
Animals and Long-Term PTX Kindling Protocols
Male Sprague-Dawley rats (initial body weight 220-250 g) were housed under standard conditions. Animals were cared for and handled in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (NIH publications).
PTX kindling was done as described [15, 34] . Briefly, rats (n = 110) received a daily injection (i.p.) of PTX (2.25 mg/kg; 1.5 mg/ ml suspended in saline; Sigma) for 20 days, and control rats (n = 10: 6 for Western blot and 4 for immunocytochemical staining) received a daily injection of vehicle for the same period. Rats were observed for 45 min after each administration, and seizures were recorded according to the scale devised by Racine [35] . After stage 4 or 5 seizures on 3 consecutive days, rats were visually videomonitored and monitored by electroencephalogram (EEG) after treatment with PTX. Stage 4 and 5 animals with simultaneous EEG showing epileptiform discharges (n = 37) were used in subsequent experiments [36] . The kindled rats were divided into four groups at random (n = 5-6 for Western blot and n = 3-4 for immunocytochemical staining): (1) PTX, (2) PTX rekindling, (3) Dia and (4) 5-HD. These rats were video-monitored (40 h/week) for spontaneous motor seizures for 2 weeks after the 20-day kindling. At 14 days after the last drug treatment of the 20-day protocol, rats in the PTX rekindling, Dia and 5-HD groups were again treated with PTX (2.25 mg/kg), and the sham and PTX groups received the same volume of vehicle alone. Preconditioning with Dia (1.9 mg/kg, 1 mg/ml in saline), a mitoK ATP channel opener [37] , and 5-HD (1 mg/kg, 1 mg/ml in saline), a mitoK ATP channel blocker, was done by injection (i.p.) once a day for 3 days, and the last injection was done 1 h before the PTX retreatment. Rats were video-monitored for 45 min after each administration, and seizures were recorded according to the scale devised by Racine [35] . Each animal was EEG monitored in a 4-hour recording period for evaluating the seizure frequency, then killed by decapitation 7 days after the last treatment.
Preparation of Cytosolic Extracts, Crude Synaptic Membrane Fraction and Western Blot Analysis
The whole-cell protein extraction from the cultured astrocytes was done with CelLytic M solution (Sigma) according to the manufacturer's instructions.
We used the method of Danbolt et al. [38] for preparation of cytosolic extracts and crude synaptic membrane fractions from the hippocampus (see online suppl. methods for details). Crude synaptic membrane fractions and cytosolic extracts were frozen and stored at -80 ° C. Protein determination was done with a modified Bradford assay (Sigma). Samples were normalized to equal concentrations of protein. For Western blot analysis, total protein (50 g) was separated by electrophoresis in a 12% (w/v) polyacrylamide gel. The blots were incubated overnight at 4 ° C first with primary antibody connexin 43 (Cx43, 1: 2,000; Chemicon), Cx45 (1: 2,000; Chemicon), Cx36 (1: 1,000; Chemicon) and Cx30
(1: 1,000; Chemicon), then with horseradish peroxidase-conjugated IgG (Sigma), and last with an ECL kit. The optical density of the films was quantified by the free software (Image J 1.4) and calculated as a value of integrated densities. Data were converted to relative optical density as percentages with ␤ -actin (1: 5,000, Sigma) designated as 100%.
Immunocytochemical Staining and Semiquantification
Every eighth section between bregma -3.30 mm and -5.80 mm was selected for detecting the expression of Cx43 and Cx45 in the hippocampus (n = 3-4; online suppl. fig. S1A ; see online suppl. methods for brain section preparation).
Sections were immunostained by blocking, then incubated overnight (4 ° C) with primary antibodies followed by secondary antibodies conjugated to fluorescent labels. The combination of primary and secondary antibodies is shown in online supplement table 1. All fluorescent conjugated secondary antibodies were purchased from Jackson ImmunoResearch (West Grove, Pa., USA). Primary antibodies were: Cx43 and Cx45 (1: 200; all from Abcam, Inc.); glial fibrillary acidic protein (GFAP; 1: 500; Harlan), a marker for mature astrocytes; NG2 (1: 300; Chemicon), a marker for oligodendrocyte precursor cells; Map2 (1; 500; Chemicon), a marker for mature neuron; NeuN (1: 500; Chemicon), a marker for mature neuron, and doublecortin (DCX, 1: 200; Santa Cruz), a marker for immature neuron.
Immunoactivity was observed and recorded under a confocal microscope (Zeiss 510) by using a multichannel configuration with the same scan setting used for each section. Five views in CA1, CA2, CA3 and dentate gyrus (DG) per section were quantified by using ImageJ 1.41 with the Measure RGB plugin. We used the Co-localise RGB plugin for Cx43/GFAP and Cx45/GFAP, or Cx43/Map2 and Cx45/Map2 colabeling (online suppl. fig. S1B ). The density of colabeling from each view was normalized to the total density of Cx43 and Cx45.
Data Analysis
All data are shown as mean 8 standard error of the mean (SEM). The experimental data were analyzed statistically by oneway analysis of variance and post-hoc multiple comparisons with Fisher's least significant difference test. p ! 0.05 was chosen as the level of statistical significance.
Results
Activation of Astrocytic mitoK ATP Channels
Facilitated GJIC LY diffused into a large population of astrocytes extending over several rows in control astrocytes, but in cultures with AGA, a GJ blocker, LY was confined to the loaded astrocytes along most of the scrape lines ( fig. 1 ) . Interestingly, Dia, a selective mitoK ATP channel opener, enhanced the GJIC significantly, and we found the layers of LY-loaded cells were more than twice as many as in the controls and four to five times as many as in the AGAtreated cultures (p ! 0.05 in each case). However, 5-HD, a mitoK ATP channel blocker, substantially inhibited the GJIC. When treated with AGA or 5-HD, the robust effects exerted by Dia were not totally blocked, indicating that activation of astrocytic mitoK ATP channels facilitated GJIC.
Activation of Astrocytic mitoK ATP Channels Attenuated GJ Blocker-Induced Inhibition of Recovery of Fluorescence
Control astrocytes exhibited a progressive recovery of fluorescence after bleaching, but with AGA the recovery of fluorescence was severely blocked ( fig. 2 a, b) . Although activation of astrocytic mitoK ATP channels with Dia did not show an elevated recovery of fluorescence compared to the controls at each time point, the levels of comparative fluorescence intensity recovery (CFIRP) were improved substantially by Dia at 5 min in Dia + AGA-treated cultures compared to those in AGA-treated astrocytes (p ! 0.001). In contrast, blocking of astrocytic mitoK ATP channels with 5-HD showed that CFIRP was inhibited severely at each time point, and it was unable to achieve the control level at 8 min (CFIRP 67.7%). Unexpectedly, 5HD + AGA gave control levels of recovery at 8 min.
Opening of Astrocytic mitoK ATP Channels Alleviated KA-Induced Inhibition of GJIC Treatment with KA decreased the CFIRP significantly at 1, 2 and 5 min after bleaching compared to the controls, but Dia alleviated this KA-induced inhibition of GJIC. In contrast, 5-HD and AGA severely blocked the recovery of GJIC, but in the Dia + AGA + KA cultures, the CFIRP was enhanced substantially at each time point compared to that with AGA + KA ( fig. 2 c, d) .
Activation of Astrocytic mitoK ATP Channels Reversed KA-Induced Downregulation of Cx43 and Cx30 Protein Expressions in vitro
Western blot analysis showed that KA decreased the expressions of Cx43 (P2) (active form). Dia could reverse the KA-induced downregulation, but the level of P2 form was downregulated substantially in the 5-HD + KA cultures. In addition to changes of the levels of the P2 form, there were changes in the overall levels of Cx43. The differences of total Cx43 expression among groups were similar to the patterns of the P2 form except for Dia + KA versus KA (p 1 0.05). For Cx30, we saw the same effects regulated by the astrocytic mitoK ATP channels, Dia reversed the KA-induced downregulation, while 5-HD further downregulated its expression ( fig. 3 ) .
Manipulation of mitoK ATP Channels Regulated the Cx Protein Expression in the Hippocampus of PTX-Kindled Rats
The Western blot results showed that in the PTX group during the seizure-free interval, the expression of Cx43 (P2), Cx45 and Cx30 was downregulated significantly compared to the controls. In the PTX-rekindling rats, only Cx43 was substantially upregulated compared to the PTX group. Pretreatment with Dia enhanced the expression of Cx43, Cx45 and Cx30 compared to the PTX group without rekindling, and pretreatment with 5-HD decreased their expression compared to those in the Dia rekindling group. Manipulation of the mitoK ATP channels had no significant effect on Cx36 expression after PTX rekindling. In addition, we found a downregulation in the levels of the P0 and P1 form of Cx43 after PTX rekindling with or without pretreatment with Dia/5-HD ( fig. 4 ) . The results of immunofluorescent staining support our Western blot analysis results showing that the expression of Cx43 was downregulated significantly in the PTX group in the whole hippocampus compared to the controls. After PTX rekindling, Cx43 expression was upregulated but still below the level of the controls. Pretreatment with Dia enhanced Cx43 expression significantly only in the CA3 region. In contrast, pretreatment with 5-HD decreased Cx43 expression in the entire hippocampus ( fig. 5 a and online suppl. fig. S3A-C) .
The expression of Cx45 was downregulated significantly in the hippocampus in the PTX group compared to the controls but not the CA3 region, where the level was higher than that in the controls. After PTX rekindling, Cx45 expression was upregulated slightly in the DG and CA1 regions, and increased significantly in the CA2 and CA3 regions. Pretreatment with Dia enhanced its expression significantly in the whole hippocampus, but pretreatment with 5-HD decreased its expression, except in the CA3 region after seizures ( fig. 5 b and online suppl. fig. S3A-C) .
Activation of mitoK ATP Channels Increased Cx Expression in Glial Cells in the Hippocampus of PTX-Kindled Rats
In the PTX group, the levels of Cx43/GFAP or Cx45/ GFAP colabeling were not significantly different from those of controls. After PTX rekindling, the level of cola- beling did not change markedly. Activation of mitoK ATP channels with Dia did increase the levels of colabeling across the entire hippocampus, except Cx45/GFAP in the CA2 region, compared to that in the PTX rekindling rats. In contrast, blocking of mitoK ATP channels with 5-HD did not decrease the levels of colabeling significantly ( fig. 5 c, 6 , 7 ) . Interestingly, we found that Cx43 was highly expressed cytoplasmically in the hippocampus (online suppl. fig. S4-S6) . By analyzing the phenotypes of these cells after seizures, we found that Dia robustly increased the total numbers of Cx43/NG2 colocalizing cells in the whole hippocampus (online suppl. fig. S6 ), but decreased the numbers of Cx43/Map2 colocalizing cells in the CA2 region substantially. By contrast, the level of Cx45/Map2 colabeling was not changed significantly in the PTX group except in the CA3 region, compared to that of the controls. After PTX rekindling, this colabeling was not altered significantly. Dia increased the levels in some areas compared to that of PTX rekindling, but significant differences were detected only in the DG region. However, 5-HD substantially decreased the levels in the DG and CA3 regions in comparison to Dia ( fig. 5 c and online suppl.  fig. S4 ).
Discussion
Main Findings
Here, we report new findings regarding how the astrocytic mitoK ATP channels regulate GJIC in the hippocampus, which might contribute to epileptogenesis in the rat. While activation of astrocytic mitoK ATP channels enhanced the GJ coupling, blocking of astrocytic mitoK ATP channels decreased the astrocytic GJ coupling. Opening astrocytic mitoK ATP channels alleviated KA-induced dysfunction of GJIC. Finally, activation of mitoK ATP channels improved the GJ coupling in the hippocampus in chronic epileptic rats, as we found that the mitoK ATP channel opener substantially increased the levels of Cx43/ GFAP or Cx45/GFAP colabeling in the hippocampus after seizures. We suggest that the mechanism whereby astrocytic mitoK ATP channels contribute to the pathogenesis of neurodisorders, in particular epileptogenesis, might be partly through the regulation the GJ-coupled spatial buffering in the hippocampus, in addition to the neuronal K ATP channel-modulated excitability.
Astrocytic K ATP Channels and GJ Coupling
The role of astrocytes in the brain has come under intense scrutiny in recent years. Astrocytes have been recognized to actively modulate neuronal communication [39] , in addition to their more established functions in regulating the extracellular milieu, which are still incompletely understood. K ATP channels within the brain are enriched in neurons as well as in glial cells [40] [41] [42] , but until now little was known about the roles of astrocytic sK ATP /mitoK ATP channels in the brain. More recently, it has been revealed that activation of astrocytic K ATP channels, particularly mitoK ATP channels, improves the function of glutamate transporters in astrocytes, and this is supposed to be beneficial for astrocytes in exerting their effects on neuronal function through glutamate transporters to maintain stimulation [23] , thus indicating that astrocytes might affect neuronal activity through a variety of specific mechanisms. In the current study, we showed that activation of mitoK ATP channels enhanced the GJ coupling; in contrast, blocking mitoK ATP channels substantially inhibited GJ coupling in astrocytes [43, 44] . These results indicate that astrocytic mitoK ATP channels exert their effects on neuronal function partly through GJIC. However, this was seemingly inconsistent with an earlier report that Dia inhibited GJ permeability and sK ATP channel blockers facilitated GJ permeability in astrocytes [45] . We think sulfonylureas and membrane openers mimic the effects of ATP on the sK ATP channels, which might suggest that intracellular energy status of the astrocytes might regulate intercellular communication through
GJs. Activation of mitoK ATP channels could sustain its own metabolic machinery [46] and the subsequent increase in ATP would inhibit the sK ATP channels, which would result in an increase in GJ permeability [45] . However, if inhibition of mitoK ATP channels leads to compromised energy reserves of the astrocytes [46] , the sK ATP channels would be activated, resulting in a decrease in GJ permeability. Another possibility is that the effect of Dia on GJIC is not dose dependent if its concentration was 1 0.1-0.15 m M as observed in our experiments (not shown) [45] . Finally, we used the more specific technique of FRAP (versus scrape-loading dye transfer) to verify this regulation by astrocytic mitoK ATP channels on GJIC, and applying 5-HD, a selective mitoK ATP channel blocker, as a control in which the results were found to be contrary to what happened after Dia administration. A study examining islets and ␤ -cells from the K ATP channel in transgenic mice found that a small percentage of K ATP channel activity of the ␤ -cells is sufficient to maintain strong glucose-dependent functions, but inhibition of GJs caused complete loss of K ATP channel activity in the control of membrane potential [47] , which supports our conclusion that K ATP channels and GJs might influence each other synergistically.
However, this will not always be the case because we found that 5-HD + AGA gave a faster recovery of fluorescence at 5 min and 8 min than either drug alone. We did not observe the same phenomenon after treatment with KA, where the effect was very similar to that of either drug alone. Unfortunately, we are not certain what really happened under these severe conditions which might involve multiple mechanisms including ion buffering and metabolic machinery, or the activation of some compensatory mechanisms.
Astrocytic K ATP Channels and Astrocytic GJs in Epileptogenesis
The hallmark of K ATP channels is their regulation by intracellular nucleotides. Inhibition by ATP but stimulation by MgADP [48] links neuronal metabolism to excitability, and thus they are thought to play an important role in protecting cells from neuronal death caused by hypoxia, ischemia or metabolic inhibition [49, 50] . It has been reported that neuronal K ATP channels show an ability to adjust cell excitability [11] [12] [13] . Pharmacological and genetic studies have provided evidence to further support the roles of neuronal K ATP channels in the control of neuronal excitability and seizure propagation by depolarizing presynaptic neuron and subsequently by inhibiting the release of excitatory neurotransmitter, or by regulating GABA transporters [1, [14] [15] [16] [17] [18] [19] . However, little is known about the roles of astrocytic sK ATP /mitoK ATP channels in epileptogenesis.
Because of the improved understanding of the molecular events underlying the physiological functions of astrocytes, it is believed that reactive astrocytes in epileptic tissue both promote and oppose seizure development through a variety of specific mechanisms [51] . Astrocytic GJs play an important role in the generation of epileptiform events [52] [53] [54] [55] . Wallraff et al. [24] observed that slices of mice with GJ coupling-deficient astrocytes displayed a reduced threshold for the generation of epileptiform events, indicating that elevated astrocytic GJ coupling might abolish the generation of epileptiform activities.
We demonstrated that activation of mitoK ATP channels attenuated the behavioral outcomes of seizures in chronic epileptic rats (online suppl. fig. S2 ). Furthermore, we found that opening of astrocytic mitoK ATP channels alleviated neurotoxin-induced dysfunction of GJIC in cultured astrocytes and increased GJ coupling after seizure in vivo. Together, our results indicated that the anticonvulsant action of mitoK ATP channel openers [15] stemmed, probably in part, from upregulating the astrocytic GJ coupling against the seizure generation as well as adjusting the astrocytic GJ coupling against the seizure propagation, in addition to the opening neuronal K ATP channels to limit cell excitability. Our results indicate that local alterations in K ATP channel function could have variable effects on the actual level of hyperactivity in the epileptic brain.
Composition of Astrocytic GJs, GJ Coupling and GJ Subunit Protein Expression
Generally, Cx43 and Cx30 are expressed in astrocytes, Cx45 and Cx36 are expressed in neurons, and Cx32 is expressed in oligodendrocytes [56] . Actually, the neuronal-glial coupling is not fully understood [57] . LM immunofluorescence analysis of astrocytic Cx43 revealed that a small portion of GJs ( ! 5%) was distributed along the surface of oligodendrocyte cell bodies (identified by labeling for the oligodendrocyte marker enzyme CNPase) [58, 59] . In the current study, we also found that Cx43 was expressed in neuronal and oligodendrocytic cell bodies (online suppl. S4-S6). It was revealed recently that neurons control the expression of the two major astrocytic GJ proteins by upregulating Cx43 in astrocytes cultured with neurons and by inducing Cx30 to form functional GJ. These effects require close interactions with neurons and are reversed by excitotoxic treatments that lead to neuronal death and, when applied in vivo, trigger significant modifications in the expression of both Cxs in reactive astrocytes [60] . Our results support this opinion. We found that Cx43 was upregulated in the entire hippocampus ( fig. 5 c) , and its colabeling with Map2 (online suppl. fig. S4 and S7) and NeuN (online suppl. fig. S5 ) was enhanced in the CA2 and CA3 regions after a seizure. After treatment with Dia, Cx43 was upregulated only in the CA3 region ( fig. 5 b) , and its colabeling with GFAP ( fig. 5 c  and fig. 6 , 7 ) and NG2 (online suppl. fig. S6 ) was enhanced significantly in the entire hippocampus; in addition, colabeling with Map2 was downregulated in the CA2 region (online suppl. fig. S7 ) at 7 days after seizure.
We think this could be due to the mitoK ATP channels either directly modulating astrocytic GJ coupling or through controlling neuronal activity to regulate Cx expression and its function [60] .
Pathophysiological Implications and Perspectives
As mentioned above, pharmacological evidence has suggested that K ATP channel openers are effective anticonvulsants [16] [17] [18] [19] . However, little is known about the anticonvulsant effect of activation of astrocytic K ATP channels, particularly of astrocytic mitoK ATP channels, and its possible mechanism. Here, to our knowledge, we show for the first time that the anticonvulsant action of K ATP channels is achieved, at least partly, by enhancing the astrocytic mitoK ATP channel-regulated GJ coupling in addition to the neuronal K ATP channel-modulated excitability. Therefore, the present study reveals a novel pharmacological profile of astrocytic K ATP channel openers as regulators of GJ coupling, and provides a new strategy for anti-epilepsy treatment. Upregulation of Cx43, Cx45 and Cx30 in epileptic tissue ( fig. 4 , 5 a, b) might reflect adaptive consequences rather than a causation of seizure activity.
In addition, availability of animals with ablation of astrocytic sK ATP /mitoK ATP channels or astrocytic Cxs or precisely selective openers/blockers of astrocytic sK ATP / mitoK ATP channels or GJs might also promote a better understanding of the proposed roles of astrocytic sK ATP / mitoK ATP channel-regulated GJ couplings in glia-related transcellular signaling pathways involved in the epileptogenesis of the brain.
